Sana's Terry Fry leads new $200M cell and gene therapy institute at University of Colorado
A new cell and gene therapy center is taking shape in the Rockies, one that hopes to raise hundreds of millions of dollars in the next few years. And they’re getting a prominent biotech leader to kick things off.
The University of Colorado’s Anschutz Medical Campus established the new Gates Institute, the school announced Wednesday, with the goal of raising $200 million in the next five years. Terry Fry, the well-known hematologist and head of T cell therapeutics at Sana, will step in as the institute’s first executive director.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,200+ biopharma pros reading Endpoints daily — and it's free.